(PharmaNewsWire.Com, March 21, 2017 ) According to the report Latin America Antibodies Market, published by Market Data Forecast, the Latin America market projected to reach USD 11.406 billion by 2021, at a CGSR of 8.41% from 2016 to 2021.
Antibodies (Abs) are proteins produced by differentiated B-Cells (Known as Plasma cells) that are used for immune system to detect and neutralize pathogens such as Viruses, bacteria and foreign proteins. Antibodies can be triggered by and directed at microorganisms, toxins, or foreign proteins. These antibodies are used as both diagnostics and Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, asthma, macular degeneration, Crohns disease, and hypercholesterolemia.
Some of the major factors that are influencing the Latin America Antibodies market are raising rate of adoption to therapeutic antibodies in cost sensitive market, quick approval for breakthrough therapies by regulatory authorities, innovative products, growing chronic illnesses due to shift increasing population and growing longevity, and adoption of diagnostic antibodies. Increasing cost of treatment and side effects associated with antibodies treatment are the major factors that are hindering the growth of the market.
The Latin America Antibodies Market is segmented as following:
Based on Product Type: Monoclonal Antibodies Murine Chimeric Humanized Human Polyclonal Antibodies Type I Type II Type III Type IV Type V Type VI Type VII Type VIII Antibody-Drug Complexes Immunogen Technology Seattle Genetics Technology Immunomedics Technology Based on Indication: Cancer Autoimmune Diseases Infectious Diseases Cardiovascular Diseases CNS Disorders Others (Inflammatory, Microbial Diseases, & Other) Based on End User: Hospitals/Clinics Research Institute Diagnostic Laboratories Based on Application: Medical Experimental Western Blot ELISA Radioimmune Assays Immunofluorescence Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)
The key players in Latin America Antibodies Market are Pfizer Inc., Abbott Diagnostics, Novartis AG, Bristol-Myers Squibb, Eli Lilly and company, A.G. Scientific, Inc., F. Hoffmann-La Roche Ltd., ThermoFisher Scientific Inc., AbbVie Inc.
The Latin America Antibodies Market study offers the following deliverables: Latin America, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the Latin America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: